The continuous renal replacement therapy machine market has seen considerable growth due to a variety of factors.
• The continuous renal replacement therapy machine market has seen strong growth in recent years. It will grow from $1.26 billion in 2024 to $1.38 billion in 2025, at a compound annual growth rate (CAGR) of 9.1%.
The growth drivers include the increasing prevalence of acute kidney injury, sepsis management, the aging population, higher hospital admissions, and rising rates of chronic kidney disease.
The continuous renal replacement therapy machine market is expected to maintain its strong growth trajectory in upcoming years.
• The continuous renal replacement therapy market is projected to grow to $1.94 billion by 2029, with a compound annual growth rate (CAGR) of 8.9%.
This growth is expected due to the rise in research and clinical trials, increasing diabetes prevalence, advancements in patient monitoring, enhanced awareness and education campaigns, and the growing need for continuous therapies. Key trends include technological innovations, integration of nanotechnology, AI and predictive analytics, high-volume hemofiltration (HVHF), and improved ICU machines.
The continuous renal replacement therapy machine market is expected to grow due to the rising incidence of acute kidney injury (AKI). AKI, characterized by sudden kidney function decline, is often triggered by reduced blood flow, toxins, or infection. CRRT machines provide gentle, continuous dialysis, improving patient outcomes. Kidney Research estimated that AKI cases in the UK increased by 4% in 2022, with numbers expected to rise further by 2033.
The continuous renal replacement therapy machine market covered in this report is segmented –
1) By Type: Mobile, Fixed
2) By Modality: Slow Continuous Ultrafiltration (SCUF), Continuous Venovenous Hemofiltration (CVVH), Continuous Venovenous Hemodialysis (CVVHD), Continuous Venovenous Hemodiafiltration (CVVHDF)
3) By Age Group: Pediatric, Adult, Geriatric
4) By Application: Acute Renal Failure, Chronic Renal Failure, Other Applications
5) By End-User: Hospital, Clinic, Dialysis Center, Home Care, Other End-Users
Subsegments:
1) By Mobile: Compact Mobile CRRT Machine, Portable CRRT Machine
2) By Fixed: Standard Fixed CRRT Machine, High-Performance Fixed CRRT Machine
Companies in the continuous renal replacement therapy machine market are focusing on integrating augmented reality (AR) to improve patient monitoring and clinical outcomes. AR is used to visualize patient data in real-time, aiding clinical decisions. In March 2024, Fresenius Medical Care unveiled an AR training program for its multi-Filtrate PRO device at the International Symposium on Intensive Care and Emergency Medicine (ISICEM) in Brussels, aiming to enhance clinical outcomes.
Major companies operating in the continuous renal replacement therapy machine market are:
• Medtronic plc
• Fresenius Medical Care AG KGaA
• Asahi Kasei Corporation
• GE HealthCare Technologies Inc.
• Toray Industries Inc.
• Baxter International Inc.
• Medline Industries LP
• Terumo Corporation
• Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
• Nipro Corporation
• B. Braun Medical Inc.
• Shandong Weigao Blood Purification Products Co. Ltd.
• Nikkiso Co. Ltd.
• JMS Co. Ltd.
• NxStage Medical Inc.
• Kawasumi Laboratories Incorporated
• Guangdong Biolight Meditech Co. Ltd.
• CytoSorbents Corporation
• Quanta Dialysis Technologies Ltd.
• Nuwellis Inc.
• Medica S.p.A.
• Anjue Medical Equipment Co. Ltd.
• Infomed SA
• RenalSense Ltd.
• SWS Hemodialysis Care Co. Ltd.
North America was the largest region in the continuous renal replacement therapy machine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the continuous renal replacement therapy machine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.